Fri, Jul 25, 2014, 3:57 AM EDT - U.S. Markets open in 5 hrs 33 mins

Recent

% | $
Click the to save as a favorite.

Waste Connections Inc. Message Board

Carolyn_Novice 277 posts  |  Last Activity: 5 hours ago Member since: Feb 3, 1999
  • Reply to

    Price

    by tahoe1300 6 hours ago
    carolyn_novice carolyn_novice 5 hours ago Flag

    Folks who own index do good longterm. Hedge funds can buy or sell one stock and index goes hay wire.

    Fideleity Select Biotechnology Portfolio (MUTF:FBIOX) owns 15.51% GILD. I own this mutual funds.

    Check the Mutual fund FBIOX perframance.

    Also it owns more than 250,000 PBYI, please see the price for the last two days. It was down 20 points today and was up more than 100 points yesaterday.

    Good luck!
    Sincerely,
    Carolyn Novice

  • carolyn_novice carolyn_novice 5 hours ago Flag

    You have to learn from the smart money. See how GILD act up and down, while option writers sell and buy at the wrong time.

    Monday, July 29, 2014 will be the real action of GILD.

    Sincerely,

    Carolyn Novice

    Sentiment: Hold

  • carolyn_novice carolyn_novice 5 hours ago Flag

    If wishes were horses, beggars would ride.

    Please Google Search " If wishes were horses:' YouTube.

    Good luck!

    Stop dreaming.

    Sincerely,

    Carolyn Novice

  • Today’s volume was very heavy 8,501,229 and it looks like a top for 2014, stock should tickle down and be SOLD.

    Good luck!

    Sincerely,

    Carolyn Novice

    Sentiment: Strong Sell

  • : Stock Market Application why you are Wrong ABB 24

    Wise minority starts buying based on research
    Technicians act upon Graph, volume and historical action
    Some market advisor get into the game
    Stock moves on Volume, On Balance Volume, momentum gives buy signal
    Public following media get in
    Common folks jump in stock is going higher
    If every body is getting in, how about wise and informed minority?
    Yes informed minority seeing they have profits they will get out
    Trend reverses
    It is better to be ahead of the crown

    Public is looking at poor earning. ABB is many new ventures, please see on YouTube.

    Good luck

    Sincerely,
    Carolyn Novice

    Sentiment: Strong Buy

  • Will it also be 91 or 89?

    Who is buying and how it will effect the closing tomorrow?

    Why GS traders make 250,000 annual bouness?

    Good luck!

    Sincerely,

    Carolyn Novice

    Sentiment: Hold

  • Please keep up with options of 90..91…92..at 2:30pm

    Lot of investors and traders hate to pay 25 cent 35 cents extra above the price stock price for one more day for writing the out of money option, now it is in money.

    So before they go out for lunch, based on East Coast time and west coast lunch time. So we can say around 2:30pm we can expect GILD will start with no over head stock and free to find equilibrium/

    Be Block house like Goldman Sachs control the price with buy and sell and blocks.

    Good luck!

    Sincerely,

    Carolyn Novice

    Sentiment: Buy

  • Stock Market Application why you are Wrong GILD 91

    1. Wise minority starts buying based on research
    2. Technicians act upon Graph, volume and historical action
    3. Some market advisor get into the game
    4. Stock moves on Volume, On Balance Volume, momentum gives buy signal
    5. Public following media get in
    6. Common folks jump in stock is going higher
    7. If every body is getting in, how about wise and informed minority?
    8. Yes informed minority seeing they have profits they will get out
    9. Trend reverses
    10. It is better to be ahead of the crown

    Good luck

    Sincerely,

    Carolyn Novice

    Sentiment: Hold

  • It may hesitate but another chance for up move based on weekly volatility.

    Time to add now and be out for a short profit by weekend or a few more days

    Sincerely,

    Carolyn Novice

    Sentiment: Buy

  • Some options in money will automatic exercised based on price.

    Now the earning reaction is know….what next?

    Settlement Date …..Short Interest…..Avg Daily Volume ……Days To Cover
    6/30/2014………. 93,715,153 ………9,625,018 ………..…..9.7
    6/13/2014 ……….92,230,036……… 10,372,330…………... 8.8
    5/30/2014………... 94,135,575……… 10,329,624………….. 9.1
    5/15/2014 ………...98,243,605……….. 12,602,148………….. 7.7
    4/30/2014………… 97,322,157………. 22,080,628………….. 4.40

    Shorts are covering…..except last month

    Please look at 90….91…92…93……94……..Volume and outstanding
    Call Options Expire at close Friday, July 25, 2014……one more day

    GILD is most Biotech funds and others Mutual funds, there are options written before the earnings surprise and wrong market reaction.

    Some options were written long time ago and now GILD close to NEW HIGH, we could exercise the option and cover shorts or pay the shorts. Some may even buy the stock or go short again.

    FB did the same after the earning but look at now?

    Please do not react GILD day to day, the best way is weekly move and On Balance Volume.

    Good Luck!

    Sincerely,

    Carolyn Novice

    Sentiment: Buy

  • Reply to

    long term price

    by hikingthere 21 hours ago
    carolyn_novice carolyn_novice 20 hours ago Flag

    By Christmas it will be above $100, if shorts cover more than 95,000,000 shares. And folks like us hold and not sell. Last week GILD was up 4 points, it is like KING Buffett and needs to digest the gains. The real trading will start after the weekend review.

    Have patience!

    Good luck!

    Sincerely,

    Carolyn Novice

    Sentiment: Hold

  • Reply to

    Worst is Behind Now the Big Move ABB 23.70 BUY

    by carolyn_novice Jul 23, 2014 10:21 AM
    carolyn_novice carolyn_novice 20 hours ago Flag

    When earning are the best ABB tops out. Now the wise minority is collecting. Please see on YouTube ABB new ventures. ABB will be working in the Middle East after all the major destruction you are watching.

    This is a big move of 25 percentage, if the volume continues. I am in it for long-term. By Christmas Middle East will be back to rebuilding.

    Good luck!

    Sincerely,

    Carolyn Novice

    Sentiment: Strong Buy

  • Reply to

    GILD getting bid up in pre market

    by lbl4321 22 hours ago
    carolyn_novice carolyn_novice 20 hours ago Flag

    Please look at PCLN. Down 13 on 12 shares. Foreign orders...

    Wait till folks in US get up.

    Sincerely,
    Carolyn Novice

  • Reply to

    IBD about GILD 90

    by carolyn_novice Jul 23, 2014 11:17 PM
    carolyn_novice carolyn_novice Jul 23, 2014 11:39 PM Flag

    PBYI it was my trading account, make or lose 5 points or 45 minutes, while have my pizza with other traders,I trade lot of stocks, so you can't ponder over. I also thought GILD will be up a few points, I came close to selling at 92 after hours, but decide to hang on till weekend. Earning and technicals sometime don't work. GILD was up 4 points last week, so we get some profit taking and consolidation for a few days or weeks.

    Good luck!

    Sincerely,
    Carolyn Novice

  • carolyn_novice by carolyn_novice Jul 23, 2014 11:17 PM Flag

    Sovaldi Booms
    Gilead GILD   earnings, released after the close, vaulted 372% to $2.36 a share, beating by 58 cents. Sales leapt 136% to $6.53 billion, topping views by $67 million.
    Hepatitis C drug Sovaldi, just launched in December, generated $3.48 billion in sales, well above consensus of $2.58 billion.
    Despite political and industry protests over the $1,000-a-day pill, Gilead said 47 state Medicaid programs cover Sovaldi.
    Gilead for the first time gave full-year guidance that included Sovaldi sales: $21 billion to $23 billion vs. $6.9 billion last year. Subtracting its prior guidance, that implies Sovaldi will rake in $11.5 billion in 2014.
    But Gilead’s whisper numbers seemed to be much higher.
    “GILD reported a 2Q that soundly beat SELL side consensus, but was roughly in line with what I perceive to be buy side expectations,” wrote ISI Group analyst Mark Schoenebaum in an email to clients. He added that the new revenue guidance agrees with analysts’ estimates.
    Perhaps for that reason, Gilead stock fell fractionally late, largely erasing a 1% regular-session gain.
    Gilead’s other major drugs — HIV medicines Atripla, Truvada, Viread, Complera and Stribild — modestly topped consensus, except for Atripla.
    In its budding field of cancer medicine, Gilead also said the FDA approved its drug idelalisib, now branded Zydelig, for chronic lymphocytic leukemia, follicular lymphoma and small lymphocytic lymphoma. Analysts expect this to be a blockbuster of more modest proportions than Sovaldi, with sales peaking at $1.5 billion in 2020.
    Two other major biotechs report on Thursday: Alexion Pharmaceuticals ALXN   and Celgene CELG   .

  • carolyn_novice by carolyn_novice Jul 23, 2014 10:25 PM Flag

    Human Psychology in the Market Place
    Enthusiasm or pessimism: Again, knowledge is our best defense.

    Study of Crowds . . .
    If you study the psychology of crowds (there are several books on the subject, like The Crowd by Gustave Le Bon, Extraordinary Popular Delusions and the Madness of Crowds by Charles Mackay, Crowds and Power by Elias Cannivetti, and The Madness of Crowds by E.S.C. Coppock), you will see how people's behavior, like most cycles in life, tends to go from one extreme to another. People become ridiculously bullish or bearish, which shows why the swings go to extremes.

    A SUSPICIOUS ATITUDE IS VITAL
    This is the underlying concept that can help us think straight, bull market or bear. It’s completely essential in bear markets, when appearances are unusually deceiving. The ability to think contrary is vital to making money.

    It’s difficult to define contrary opinion.
    One must be careful not to be absurd in its application. It isn’t simply the contradiction of every opinion encountered. Neither is it safe to assume that the majority is wrong all the time. They are likely only to be wrong when there appears to be no division of opinion. The logic of this is that life is an ever-changing thing; an opinion that begins by being quite sound dates itself like everything else, so that by the time everybody has come round to holding it, it should already be history, and the set of circumstances that originally caused it have changed.

    Also since mass thinking on any matter is always tinged with exaggeration, it tends to be extremist thing. This means that a reaction must come to erase the extreme and restore balance.

  • Reply to

    anybody know...

    by wildandwacky39 Jul 23, 2014 9:11 PM
    carolyn_novice carolyn_novice Jul 23, 2014 9:50 PM Flag

    Please go to the GILD Home page, either listen earnign call or down load PDF.

    Three months
    Antiviral product sales …..$ 6,012,1446
    Sovald…………………….$3,480,326

    Six months
    Antiviral product sales …..$10,520,641
    Sovaldi…………………….$5,754,675

    Sincerely,

    Carolyn Novice

    You can email the company and get the answer. The stock price depends on future sales and products in the pipe line.

    Sentiment: Hold

  • Reply to

    All the good news is price in

    by getintoh20 Jul 23, 2014 4:53 PM
    carolyn_novice carolyn_novice Jul 23, 2014 5:00 PM Flag

    No one knew the news will be so good. GILD had to request for trading stop so every one gets the news.

    It wiil take mutual fund and hedge funds and block trading tomorrow to determine the real price. GILD will buy shares at these bargains,

    Good luck!

    Sincerely,

    Carolyn Novice

    Sentiment: Hold

  • Wait for a another day, and weekend newspapers.

    I am surprised, I expected a gap opening, look what happened to PBYI today.

  • carolyn_novice by carolyn_novice Jul 23, 2014 4:37 PM Flag

    6/30/2014 ......93,715,153 .......9,625,018 .....9.73 days

WCN
48.840.00(0.00%)Jul 24 4:05 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.